NCT04374617View on ClinicalTrials.gov

Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

April 25, 2020

Study Completion Date

May 1, 2020

Conditions
COVID-19Critical IllnessVenous ThromboembolismVenous ThrombosesVenous Thromboses, DeepVenous Thrombosis PulmonaryPulmonary EmbolismPulmonary Embolism and ThrombosisSars-CoV2SARS-CoV Infection
Interventions
DIAGNOSTIC_TEST

Duplex ultrasound and Computed Tomography Angiography

All venous thromboembolisms suspected will diagnosed with ultrasound and CT-angiography

Trial Locations (3)

08035

Vall d´Hebron Research Institute VHIR, Barcelona

Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Barcelona

08916

Hospital Germans Trias i Pujol. Universitat Autònoma de Barcelona, Badalona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT04374617 - Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 | Biotech Hunter | Biotech Hunter